# Quality Assurance Report

---

# Identity

| Field | Value |
|-------|-------|
| QA Report ID | QA-PP-0142 |
| Population Package | PP-0142 |
| Version | 1.0.0 |
| Review Status | PASS |

---

# Layer 1 — Content QA

| Criterion | Result |
|-----------|--------|
| Single educational question | PASS |
| Scope respected | PASS |
| Complete coverage | PASS |
| Internal consistency | PASS |
| Logical organization | PASS |
| Knowledge blocks complete | PASS |
| No overlap with adjacent Population Packages | PASS |
| Historical/current distinction preserved | PASS |

---

# Layer 2 — Clinical QA

| Criterion | Result |
|-----------|--------|
| Historical BP6 definition accurately represented | PASS |
| Current ClinGen governance position accurately represented | PASS |
| Consistent with ACMG | PASS |
| Consistent with AMP | PASS |
| Consistent with ClinGen SVI | PASS |
| Appropriate distinction between source assertion and independently evaluated evidence | PASS |
| Appropriate explanation of why BP6 is no longer recommended for use | PASS |
| No unsupported current-use claim | PASS |
| No unsafe medical advice | PASS |

---

# Layer 3 — Educational QA

| Criterion | Result |
|-----------|--------|
| Plain language | PASS |
| Appropriate for patients | PASS |
| Learning objectives satisfied | PASS |
| Common misconceptions addressed | PASS |
| Historical status clearly identified | PASS |
| Current status clearly identified | PASS |
| Avoids implying that a reputable source's classification automatically proves benignity | PASS |
| Appropriate explanation of evidence quality | PASS |
| Appropriate distinction between classification and evidence | PASS |

---

# Layer 4 — Governance QA

| Criterion | Result |
|-----------|--------|
| CKO completed | PASS |
| Knowledge Passport completed | PASS |
| Evidence Package completed | PASS |
| Evidence traceability complete | PASS |
| Scope maintained | PASS |
| Knowledge Graph complete | PASS |
| Historical governance preserved | PASS |
| Current governance status encoded | PASS |
| Runtime safety rule defined | PASS |
| Versioning complete | PASS |
| Repository compliant | PASS |

---

# Clinical Safety Review

| Item | Result |
|------|--------|
| No unsafe medical advice | PASS |
| No implication that BP6 is currently applicable | PASS |
| No automatic benign conclusion from a database/source assertion | PASS |
| Independent evidence evaluation emphasized | PASS |
| Current governance distinction preserved | PASS |
| Expert interpretation remains necessary | PASS |
| No disease-specific treatment recommendations | PASS |

---

# Educational Boundary Review

The Population Package successfully remains within the predefined educational boundary.

### Included

- Historical BP6 definition
- Reputable source
- Reported benign classification
- Independent evidence evaluation
- Current ClinGen governance
- Patient implications

### Excluded

- ClinVar star-rating systems
- Detailed database submission rules
- Database curation methodology
- Detailed evidence weighting
- Bayesian framework
- ACMG evidence combination rules
- Laboratory workflow
- Gene-specific BP6 specifications
- Treatment recommendations

The **Atomic Knowledge Principle** has been fully preserved.

---

# Runtime Safety Review

The package contains an explicit governance boundary:

> **BP6 is historical knowledge and is not a currently recommended standalone benign evidence criterion.**

The Safe Medical AI System must therefore avoid generating statements such as:

- "BP6 can currently be applied to classify this variant as benign."
- "A reputable database reporting benign status is sufficient to establish benign evidence."
- "BP6 is routinely used in current variant interpretation."

Instead, the system should communicate that:

- BP6 existed historically;
- current ClinGen governance recommends against its use;
- underlying evidence should be independently evaluated whenever possible.

---

# Final Quality Decision

## PASS

PP-0142 satisfies the locked **Gold Population Package Specification v1.0**.

Approved as the official Population Package for:

> **PP-0142 — BP6 (Reputable Source Recently Reports Variant as Benign, but the Evidence Is Not Available for Independent Evaluation)**

---

# Reviewer Notes

This Population Package is intentionally different from the preceding BP packages because **BP6 has a historical status rather than a current-use status**.

The package preserves the original ACMG/AMP concept while explicitly encoding the subsequent ClinGen SVI recommendation that BP6 **not be used**.

The central safety principle is:

> **A classification reported by another source is not automatically equivalent to independently evaluated evidence.**

This distinction is essential for a Safe Medical AI System and prevents historical ACMG/AMP terminology from being incorrectly presented as current clinical practice.

The package therefore maintains strict adherence to the **Atomic Knowledge Principle** while preserving the evolution of variant interpretation governance.